Skip to main content

Table 1 Participant characteristics given as mean (SD) or frequency (%)

From: Sex hormones and gene expression signatures in peripheral blood from postmenopausal women - the NOWAC postgenome study

Age, years 55.7 (3.6)   
BMI, kg/m2 25.6 (4.3)   
   Among women not using medication
Sex hormone concentration   1.quartile (low)
Cut-off (mean)
4.quartile (high)
Cut-off (mean)
   Estradiol nmol/L 0.10 (0.09) <0.05] (0.05) >0.08 (0.14)
   Progesterone nmol/L 0.99 (0.67) <0.55] (0.44) >1.21 (1.79)
   Testosterone nmol/L 1.16 (0.74) <0.66] (0.50) >1.54 (2.14)
   FSH IU/L 70.2 (28.0) <56.4] (44.5) >91.2 (106.4)
   SHBG nmol/L 47.6 (21.8) <32.0] (24.2) >61.0 (75.1)
Medication use 182 (64%)   
   HT 52 (18%)   
E2 and E2/P systemic 32 (62%)   
E2 systemic alone 9 (17%)   
Tibolone 10 (19%)   
Vaginal treatment 9 (17%)   
   Thyroxine 20 (7%)   
   Other medication 159 (56%)   
   No medication 98 (34%)   
Number of medications used (n = 182)    
   1 medication 97 (53%)   
   2 medications 62 (34%)   
   >2 medications 23 (13%)   
Current smoker    
   Yes 75 (26%)   
   No 209 (73%)